Medical

second-line drug

second-line drug

Any therapeutic agent that is not the drug of choice, or the 1st normally used to treat a particular condition; in rheumatoid arthritis, 2nd-line agents are used when standard 'first-line' therapy–ie, anti-inflammatory agents and corticosteroids fail
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in
References in periodicals archive
In this study, we used WGS to investigate transmission of MDR and extensively drug resistant (XDR) TB strains isolated in Tunisia over a 4-year period by applying the core-genome multilocus sequence typing (cgMLST) scheme and identifying the drug-resistance marker for first-line and second-line drug resistance.
More than half of patients nationwide (60 per cent) who need a second-line drug are prescribed one of these two drugs, the study found.
Although the patient with recurrent glioblastoma has multiple choices of therapy, the 5-year survival rate is still less than 5%, and the average survival time is less than 12 months.[1] Currently, there is no single second-line drug can have survival benefits.
The head of the National Malaria Control Programme, Dr Waqo Ejersa, said the prescribed drug was only limited to a particular batch that failed to meet quality specifications as laid-down in the ministry and World Health Organization guidelines."Duo-Cotexcin is normally used as a second-line drug in the treatment of malaria in the country.
Dapsone as a cheap and safe second-line drug for chronic immune thrombocytopenia in developing countries: A prospective cohort study.
Criteria for acquired resistance were met if participants had evidence of prior MDR-TB infection or were previously treated for MDR-TB or with any second-line drug for indications other than TB.
These savings are expected to accumulate through lower second-line drug costs (second-line therapy costs ~USD350 [5,8]), but also lower service delivery costs and decreased viral load monitoring.
Current guidelines recommend digoxin as first-line therapy in patients who aren't physically active and as a second-line drug for more active patients.
National Institute for Health and Care Excellence (NICE) cite sulfonylurea drugs as the top second-line drug treatment for patients with type 2 diabetes if monotherapy with metformin fails.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.